![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospace.com/job-trends/aadi-bioscience-to-lay-off-80-of-r-d-staff
https://www.prnewswire.com/news-releases/aadi-bioscience-announces-financial-results-for-the-second-quarter-2024-and-provides-corporate-update-302216626.html
https://www.prnewswire.com/news-releases/aadi-bioscience-presents-new-nonclinical-data-demonstrating-preferential-tumor-uptake-of-nab-sirolimus-at-the-american-society-of-clinical-oncology-asco-annual-meeting-302154651.html
https://www.prnewswire.com/news-releases/aadi-bioscience-to-present-new-non-clinical-data-highlighting-combinability-of-nab-sirolimus-at-the-american-association-for-cancer-research-aacr-annual-meeting-302111705.html
https://www.prnewswire.com/news-releases/aadi-bioscience-presents-new-subgroup-analysis-of-patients-with-advanced-malignant-pecoma-of-gynecologic-origin-treated-with-nab-sirolimus-at-society-of-gynecologic-oncology-sgo-302090852.html
https://www.prnewswire.com/news-releases/aadi-bioscience-to-report-fourth-quarter-and-full-year-2023-results-and-corporate-update-302078967.html
https://www.prnewswire.com/news-releases/aadi-bioscience-to-present-multiple-posters-at-the-american-association-for-cancer-research-aacr-annual-meeting-2024-302080277.html
https://www.prnewswire.com/news-releases/aadi-bioscience-announces-publication-of-long-term-efficacy-and-safety-data-further-supporting-fyarro-for-the-treatment-of-malignant-pecoma-302077584.html
https://www.prnewswire.com/news-releases/aadi-bioscience-to-present-at-the-td-cowen-44th-annual-healthcare-conference-302071520.html
https://www.prnewswire.com/news-releases/aadi-bioscience-announces-poster-presentations-at-the-2024-american-society-of-clinical-oncology-asco-gastrointestinal-gi-cancers-symposium-302039765.html